<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>188</id><JournalTitle>EVALUATION OF THE ANTI-ASTHMATIC POTENTIAL OF BOERHAAVIA DIFFUSA (B.DIFFUSA) IN EXPERIMENTAL ANIMALS</JournalTitle><Abstract>Regardless of existing medical knowledge on allergy and asthma, the treatment of asthma still remains
unsatisfactory owing to the limitations of current therapies and associated side effects. Aqueous root extract of Boerhaavia
diffusa (B.diffusa), possess anti inflammatory property and has been used traditionally in the treatment of asthma as
mentioned in ayurvedic literature. Therefore, the present study was planned to evaluate and explore potential mechanism/s
involved in the beneficial effects of B.diffusa in asthma using various animal models. The aqueous root extract of B.diffusa
was studied at3different doses (200mg/kg, 400mg/kg, and 600 mg/kg) using 3 animal models. The models used for
evaluating the antiasthma potential of B.diffusa were ovalbumin-induced allergic response in rats, clonidine-induced mast
cell degranulation in rats, and model of bronchial hyperresponsiveness induced by histamine aerosol in guinea pigs. Each
model consisted of 5 groups (Group 1: disease control; Group 2: positive control; Group 3: B.diffusa 200mg/kg; Group 4: B.
diffusa 400 mg/kg, Group 5: B. diffusa 600 mg/kg. All the 3 doses of B diffusa showed significant reduction in total
leucocyte count, eosinophils, neutrophils and mononuclear cell count as compared to disease control(p<0.001). The
reduction of peribronchial inflammation in both dexamethasone (p<0.001) and B. diffusa600 mg/kg (p<0.05) group was
found to be significant compared to disease control group. The percentage of intact mast cells was found to be significantly
higher in the sodium chromoglycate and B. diffusa 200, 400, and 600 mg/kg as compared to the disease control group
(p<0.001).Increase in the preconvulsion time was observed with all 3 doses of B.diffusa, significant as compared to disease
control group (p<0.001). These findings corroborate that B.diffusa suppresses the airway inflammation, demonstrates
membrane stabilizing property and reduces airway hyperresponsiveness.</Abstract><Email>drtejalchetan@gmail.com</Email><articletype>Research</articletype><volume>8</volume><issue>2</issue><year>2018</year><keyword>Bronchial hyper reactivity, Bronchoalveolar lavage, Mast cell degranulation, Ovalbumin, Pre convulsion time</keyword><AUTHORS>Tejal Chetan Patel,Parvan Ananda Shetty,Dinesh Amrith Uchil,Sharmila Vinayak,Jalgaonkar</AUTHORS><afflication>Tejal Chetan Patel,Parvan Ananda Shetty,Dinesh Amrith Uchil,Sharmila Vinayak,Jalgaonkar</afflication></Article></Articles>